Home
>
National Drug Code (NDC)
>
Amlobenz
Amlobenz - 21695-916-30 - (Amlobenz)
Drug Information of Amlobenz
| Product NDC: | 21695-916 |
| Proprietary Name: | Amlobenz |
| Non Proprietary Name: | Amlobenz |
| Active Ingredient(s): | 10; 20 mg/1; mg/1 & nbsp; Amlobenz |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Amlobenz
| Product NDC: | 21695-916 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077183 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100419 |
Package Information of Amlobenz
| Package NDC: | 21695-916-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (21695-916-30) |
NDC Information of Amlobenz
| NDC Code | 21695-916-30 |
| Proprietary Name | Amlobenz |
| Package Description | 30 CAPSULE in 1 BOTTLE (21695-916-30) |
| Product NDC | 21695-916 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Amlobenz |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100419 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
| Strength Number | 10; 20 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
